RAFAEL HOLDINGS, INC. Marketable Securities, Gain (Loss)
RAFAEL HOLDINGS, INC. (RFL) reported Marketable Securities, Gain (Loss) of $749.00 thousand for the 12-month period ending 2021-07-31, per its 10-K filed 2022-10-31.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesGainLoss · last filed 2022-10-31
- RAFAEL HOLDINGS, INC. marketable securities, gain (loss) for the quarter ending 2021-07-31 was $0.00.
- RAFAEL HOLDINGS, INC. marketable securities, gain (loss) for the quarter ending 2021-04-30 was $0.00.
- RAFAEL HOLDINGS, INC. marketable securities, gain (loss) for the quarter ending 2021-01-31 was $0.00.
- RAFAEL HOLDINGS, INC. marketable securities, gain (loss) for the quarter ending 2020-10-31 was $749.00K.
- RAFAEL HOLDINGS, INC. marketable securities, gain (loss) for fiscal 2021 was $749.00K.
- RAFAEL HOLDINGS, INC. marketable securities, gain (loss) for fiscal 2019 was $330.00K.
| Period end | Marketable Securities, Gain (Loss) 3 month | Marketable Securities, Gain (Loss) 6 month | Marketable Securities, Gain (Loss) 9 month | Marketable Securities, Gain (Loss) 12 month |
|---|---|---|---|---|
| 2021-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $0.00 derived: sum of 2 quarters · filed 2022-10-31 | $0.00 derived: sum of 3 quarters · filed 2022-10-31 | $749.00K 10-K · filed 2022-10-31 |
| 2021-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-06-14 | $0.00 derived: sum of 2 quarters · filed 2022-06-14 | $749.00K 10-Q · filed 2022-06-14 | |
| 2021-01-31 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-03-17 | $749.00K 10-Q · filed 2022-03-17 | ||
| 2020-10-31 | $749.00K 10-Q/A · filed 2022-02-28 | |||
| 2019-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-29 | $0.00 derived: sum of 2 quarters · filed 2020-10-29 | $7.00K derived: sum of 3 quarters · filed 2020-10-29 | $330.00K 10-K · filed 2020-10-29 |
| 2019-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-09 | $7.00K derived: sum of 2 quarters · filed 2020-06-09 | $330.00K 10-Q · filed 2020-06-09 | |
| 2019-01-31 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-03-05 | $330.00K 10-Q · filed 2020-03-05 | ||
| 2018-10-31 | $323.00K 10-Q · filed 2019-12-09 | |||
| 2018-04-30 | $24.00K 10-Q · filed 2019-06-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |